Revenue in the eHealth segment is projected to reach US$64.09bn in 2022.
Revenue is expected to show an annual growth rate (CAGR 2022-2027) of 11.31%, resulting in a projected market volume of US$109.50bn by 2027.
User penetration will be 25.66% in 2022 and is expected to hit 36.12% by 2027.
The average revenue per user (ARPU) is expected to amount to US$32.82.
In global comparison, most revenue will be generated in China (US$19,600.00m in 2022).
The "eHealth" segment contains the user and revenue development of four categories: (1) eHealth Devices, (2) eHealth Apps, (3) Online Pharmacy, and (4) Online Doctor Consultations. This market includes devices and apps that help users monitor and analyze lifestyle-related aspects and improve their overall health.
eHealth Devices comprise biosensors that collect information on a variety of health parameters and vital signs of a person (blood pressure, temperature, blood glucose, weight) by reading or measuring this data and transmitting it via electric signals.
eHealth Apps include various apps that help users monitor/detect/analyze physical health conditions. Contraception and fertility apps provide users with guidelines on self-care, family planning, and birth control topics, raise their awareness, and offer monitoring functions. Medication checker apps provide users with useful dosage intake guidelines, drug interaction information, and personal medication records. The user base of eHealth Apps covers paying and non-paying customers. The revenue figures only include revenues generated from paid apps offering premium options and from in-app purchases; revenues from app downloads and advertising revenues are not included.
The Online Pharmacy segment includes over-the-counter medicine that can be purchased without a medical prescription through online sales channels. The segment comprises analgesics, cold and cough medication, digestives and intestinal remedies, skin treatment products, as well as vitamins and minerals. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.
Online doctor consultations or teleconsultations make up one of the biggest shares in the telemedicine industry. This segment focuses solely on remote consultations between patients and doctors conducted via online channels, either websites or mobile apps. These consultations can be organized by both public and private medical institutions. Online appointment scheduling, online medical records, and online prescriptions are not considered. The user figures include those who have already used online doctor consultation services in the past 12 months and prospective users who might consider using them in the future. The revenue figures cover revenues generated from paid consultations conducted via a website or mobile app.
The data only reflects B2C revenues; B2B and C2C revenues are not covered.
Contraception and fertility apps
Medication checker apps
Blood pressure meters
Natural and synthetic agents
Analgesics (e.g., Aspirin, Paracetamol)
Cough and cold remedies (e.g., Vicks VapoRub)
Vitamins and minerals
Skin treatment products
Remote consultations with doctors conducted via a website or mobile app